Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Revenue of Retractable Technologies, Inc. (RVP)
Revenue in 2023 (TTM): $43.6 M
According to Retractable Technologies, Inc.'s latest financial reports the company's current revenue (TTM) is $43.6 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Retractable Technologies, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $43.6 M | $9.11 M | $-3,960,980 | $-8,916,197 | $-7,011,036 |
| 2022 | $94.82 M | $28.25 M | $7.59 M | $5.16 M | $5.08 M |
| 2021 | $188.38 M | $95.35 M | $75.06 M | $74.95 M | $56.06 M |
| 2020 | $81.86 M | $37.01 M | $27.17 M | $26.07 M | $24.22 M |
| 2019 | $41.8 M | $14.14 M | $4.18 M | $3.16 M | $3.15 M |
| 2018 | $33.27 M | $10.22 M | $-549,771 | $-1,353,261 | $-1,339,943 |
| 2017 | $34.49 M | $9.97 M | $-2,877,934 | $-3,923,646 | $-3,736,038 |
| 2016 | $29.83 M | $10.34 M | $-2,151,493 | $-3,693,775 | $-3,694,907 |
| 2015 | $29.55 M | $10.57 M | $-2,324,568 | $4.32 M | $4.31 M |
| 2014 | $34.52 M | $12.02 M | $-1,049,100 | $-2,346,428 | $-2,354,605 |
| 2013 | $30.79 M | $10.31 M | $-4,608,053 | $-6,122,880 | $-6,213,852 |
| 2012 | $33.64 M | $11.18 M | $-2,556,006 | $-4,123,074 | $-4,132,892 |
| 2011 | $32.1 M | $10.9 M | $-2,715,491 | $1.43 M | $1.42 M |
| 2010 | $36.22 M | $12.4 M | $-4,866,759 | $2.22 M | $2.4 M |
| 2009 | $38.98 M | $13.52 M | $-9,246,603 | $-13,259,890 | $-9,422,300 |
| 2008 | $27.9 M | $8.23 M | $-8,191,888 | $-9,643,580 | $-9,643,580 |
| 2007 | $26.29 M | $7.99 M | $-8,515,857 | $-8,401,721 | $-6,948,104 |
| 2006 | $25.32 M | $7.55 M | $-5,287,950 | $-5,149,446 | $-3,869,484 |
| 2005 | $24.24 M | $8.81 M | $-1,509,806 | $-1,843,686 | $-1,238,323 |
| 2004 | $21.52 M | $5.11 M | $-81,339,886 | $66.87 M | $54.69 M |
| 2003 | $19.08 M | $4.42 M | $-18,473,839 | $7.71 M | $7.45 M |
| 2002 | $20.32 M | $5.33 M | $-1,778,524 | $-6,825,928 | $-6,825,928 |
| 2001 | $16.15 M | $2.82 M | $-5,517,486 | $ | $-7,215,280 |
| 2000 | $9.64 M | $1.76 M | $-8,567,888 | $ | $-10,444,609 |